You also made a comment about the seven or so countries that guide the decision-making of the Patented Medicine Prices Review Board. Do you think those are the right countries, in the sense that they're all countries for which the export of pharmaceuticals is one of their industrial strengths? One has to wonder about the prices they allow in their home country, knowing that the export of those drugs to other countries improves their balance of trade situation.
On May 14th, 2007. See this statement in context.